WELL Health Technologies Corp. (TSE:WELL - Get Free Report) hit a new 52-week high on Friday after CIBC raised their price target on the stock from C$5.00 to C$5.25. The stock traded as high as C$5.33 and last traded at C$5.28, with a volume of 2508925 shares trading hands. The stock had previously closed at C$4.93.
Separately, Ventum Financial dropped their price objective on shares of WELL Health Technologies from C$8.00 to C$7.00 and set a "buy" rating for the company in a report on Tuesday, October 29th. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, WELL Health Technologies currently has a consensus rating of "Moderate Buy" and an average target price of C$7.00.
Check Out Our Latest Stock Analysis on WELL
WELL Health Technologies Price Performance
The company has a quick ratio of 1.02, a current ratio of 1.25 and a debt-to-equity ratio of 41.57. The firm's 50-day moving average is C$4.43 and its 200-day moving average is C$4.32. The company has a market cap of C$1.33 billion, a PE ratio of 9.28, a PEG ratio of -1.93 and a beta of 1.20.
About WELL Health Technologies
(
Get Free Report)
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider WELL Health Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and WELL Health Technologies wasn't on the list.
While WELL Health Technologies currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
